bayport bombers, ltd.

70 nelson avenue
blue point, new york 11722

NYS Entity Status
ACTIVE

NYS Filing Date
FEBRUARY 22, 2013

NYS DOS ID#
4364092

County
SUFFOLK

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC NOT-FOR-PROFIT CORPORATION

Name History
2013 - BAYPORT BOMBERS, LTD.









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Pride 2017: New York’s L.G.B.T.Q. Story Began Well Before Stonewall
    By LIAM STACK - Monday Jun 19, 2017

    The gay bar’s 1969 patron-police battle, hailed as a starting point, actually followed many events in the city, now mapped in a sites project.

    Source: NYT > Home Page
  • Can America Afford a New Nuclear Bomber?
    Sunday Jul 27, 2014

    In an era of belt-tightening, the Pentagon hopes to spend $550 million each for new bombers. Too much? Air Force Major General Garrett Harencak talks with The Wall Street Journal's John Bussey.

    Source: The Wall Street Journal: The Big Interview
  • Suspected Bomber Shot Dead at Brussels Train Station
    Wednesday Jun 21, 2017

    Belgian security forces shot dead a suspected terrorist who authorities said set off an explosion in the Brussels Central station Tuesday evening, but no other casualties were reported.

    Source: The Wall Street Journal: World News
  • “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
    By Ben Fidler - Wednesday Jun 7, 2017

    Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]

    Source: Xconomy New York
  • “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
    By Ben Fidler - Wednesday Jun 7, 2017

    Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Finding the Qibla in augmented reality
    Monday Jun 12, 2017

    Source: The Official Google Blog
  • Finding the Qibla in augmented reality
    Monday Jun 12, 2017

    Source: The Official Google Blog
  • Blue Apron’s up IPO is not a surprise, as unicorns fare well in 2017
    By Alex Wilhelm - Monday Jun 19, 2017

     Blue Apron’s IPO moved closer to reality this week as the firm set a price range for its shares. The company is set to go public at a higher IPO price than its last private round, undercutting worry that future unicorn IPOs may only point one direction: down.The meal-kit startup may IPO at a price between $15 and $17. At midpoint, Blue Apron is worth “just under $3… Read More

    Source: TechCrunch